Modifying tumor-associated macrophages: An important adjunct to immunotherapy

Zvi G Fridlender1, Steven M Albelda2

  • 1Institute of Pulmonary Medicine; Hadassah-Hebrew University Medical Center; Jerusalem, Israel ; Thoracic Oncology Laboratory; University of Pennsylvania; Philadelphia, PA USA.

Oncoimmunology
|February 6, 2014
PubMed
Summary

Modulating tumor-associated macrophages (TAMs) significantly enhances immunotherapy effectiveness by altering the tumor microenvironment. TAM-activating agents represent a promising addition to immunotherapy strategies in clinical trials.

Related Concept Videos